Search research articles
Contact Us
Filters
Showing results (421-430 of 437) with videos related to
Page
of 44
Sort By:
The Science of the Total Environment
|
December 19, 2024
The risk of high-biomass HABs: Triggers and dynamics of a non-toxic bloom of Prorocentrum micans in Chilean Patagonia
Patricio A Díaz, Leila Basti, Iván Pérez-Santos, et al.
Gynecologic Oncology
|
September 29, 2016
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer
Jonathan Oh, Minal Barve, Carolyn M Matthews, et al.
Cancer Cell
|
January 15, 2016
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, et al.
Cancer Cell
|
June 12, 2019
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
January 21, 2026
The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome
Julianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Journal of Oncology Practice
|
July 2, 2013
Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment
Howard A Zaren, Suresh Nair, Ronald S Go, et al.
Scientific Reports
|
August 1, 2023
TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways
Karnika Singh, Chunhua Han, Jessica L Fleming, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
Obesity (Silver Spring, Md.)
|
June 5, 2026
Inflammation Associated With Obesity, Aging, and Amyloid Burden in Adults With Down Syndrome
Victoria L Fleming-Batayneh, Brian C Helsel, Lauren T Ptomey, et al.
Elife
|
March 26, 2025
Network segregation is associated with processing speed in the cognitively healthy oldest-old
Sara A Nolin, Mary E Faulkner, Paul Stewart, et al.
Page
of 44
Search research articles
Search
Showing results (421-430 of 437) with videos related to
Sort By:
Page
of 44
The Science of the Total Environment
|
December 19, 2024
The risk of high-biomass HABs: Triggers and dynamics of a non-toxic bloom of Prorocentrum micans in Chilean Patagonia
Patricio A Díaz, Leila Basti, Iván Pérez-Santos, et al.
Gynecologic Oncology
|
September 29, 2016
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer
Jonathan Oh, Minal Barve, Carolyn M Matthews, et al.
Cancer Cell
|
January 15, 2016
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, et al.
Cancer Cell
|
June 12, 2019
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
January 21, 2026
The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome
Julianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Journal of Oncology Practice
|
July 2, 2013
Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment
Howard A Zaren, Suresh Nair, Ronald S Go, et al.
Scientific Reports
|
August 1, 2023
TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways
Karnika Singh, Chunhua Han, Jessica L Fleming, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
Obesity (Silver Spring, Md.)
|
June 5, 2026
Inflammation Associated With Obesity, Aging, and Amyloid Burden in Adults With Down Syndrome
Victoria L Fleming-Batayneh, Brian C Helsel, Lauren T Ptomey, et al.
Elife
|
March 26, 2025
Network segregation is associated with processing speed in the cognitively healthy oldest-old
Sara A Nolin, Mary E Faulkner, Paul Stewart, et al.
Page
of 44